Randomized Phase II Dose Comparison LITESPARK-013 Study of Belzutifan in Patients with Advanced Clear Cell Renal Cell Carcinoma
ANNALS OF ONCOLOGY(2024)
Key words
belzutifan,hypoxia-inducible factor,renal cell carcinoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined